Literature DB >> 6278332

3H-Noradrenaline and 3H-5-hydroxytryptamine release from rat brain slices and its presynaptic alpha-adrenergic modulation after long-term desipramine pretreatment.

A N Schoffelmeer, A H Mulder.   

Abstract

The electrically-evoked release of 3H-noradrenaline from superfused cortex and hippocampus slices was strongly enhanced (by about 50%) after long-term (4 weeks) pretreatment with desipramine (10 mg/kg, twice daily). The release-enhancing effect of the alpha-receptor antagonist phentolamine was significantly reduced but the inhibitory effects of exogenous noradrenaline and clonidine on 3H-noradrenaline release were virtually unchanged after chronic desipramine treatment. The K+ -induced release of 3H-noradrenaline from superfused synaptosomes obtained from rats pretreated with desipramine was about 25% higher than that from synaptosomes of control animals. However, noradrenaline inhibited the K+ -induced synaptosomal 3H-noradrenaline release to the same extent (viz. by about 55%) in both cases. The release of 3H-5-hydroxytryptamine induced by 26 mM K+ from cortex and hippocampus slices was not affected by chronic pretreatment with desipramine. In addition, no change was observed in the inhibitory effect of noradrenaline o 3H-5-hydroxytryptamine release. It is concluded that long-term pretreatment with desipramine leads to selective changes in the basic mechanism(s) of noradrenaline release rather than to changes in the sensitivity of presynaptic alpha-adrenoceptors.

Entities:  

Mesh:

Substances:

Year:  1982        PMID: 6278332     DOI: 10.1007/bf00500477

Source DB:  PubMed          Journal:  Naunyn Schmiedebergs Arch Pharmacol        ISSN: 0028-1298            Impact factor:   3.000


  37 in total

1.  Development of beta-adrenergic receptor subsensitivity by antidepressants.

Authors:  S P Banerjee; L S Kung; S J Riggi; S K Chanda
Journal:  Nature       Date:  1977-08-04       Impact factor: 49.962

2.  Functional evidence for subsensitivity of noradrenergic alpha 2 receptors after chronic desipramine treatment.

Authors:  C Spyraki; H C Fibiger
Journal:  Life Sci       Date:  1980-11-17       Impact factor: 5.037

3.  On the capacity of presynaptic alpha receptors to modulate norepinephrine release from slices of rat neocortex and the affinity of some agonists and antagonists for these receptors.

Authors:  J Wemer; J C van der Lugt; C D de Langen; A H Mulder
Journal:  J Pharmacol Exp Ther       Date:  1979-12       Impact factor: 4.030

4.  Adrenergic and serotonergic receptor binding in rat brain after chronic desmethylimipramine treatment.

Authors:  D A Bergstrom; K J Kellar
Journal:  J Pharmacol Exp Ther       Date:  1979-05       Impact factor: 4.030

5.  Differential binding of antidepressants to noradrenaline and serotonin transport sites in central nerve endings.

Authors:  M Raiteri; R Del Carmine; A M Cervoni; G Levi
Journal:  Eur J Pharmacol       Date:  1979-08-15       Impact factor: 4.432

6.  Effects of presynaptic modulators on Ca2+-induced noradrenaline release from central noradrenergic neurons. Noradrenaline and enkephalin inhibit release by decreasing depolarization-induced Ca2+ influx.

Authors:  M Göthert; I M Pohl; E Wehking
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1979-05       Impact factor: 3.000

7.  Tricyclic antidepressant agents. I. Comparison of the inhibition of the uptake of 3-H-noradrenaline and 14-C-5-hydroxytryptamine in slices and crude synaptosome preparations of the midbrain-hypothalamus region of the rat brain.

Authors:  S B Ross; A L Renyi
Journal:  Acta Pharmacol Toxicol (Copenh)       Date:  1975

8.  Potentiation of responses to adrenergic nerve stimulation in isolated rat atria during chronic tricyclic antidepressant administration.

Authors:  F T Crews; C B Smith
Journal:  J Pharmacol Exp Ther       Date:  1980-10       Impact factor: 4.030

9.  Presynaptic noradrenergic alpha-receptors and modulation of 3H-noradrenaline release from rat brain synaptosomes.

Authors:  C D De Langen; F Hogenboom; A H Mulder
Journal:  Eur J Pharmacol       Date:  1979-11-23       Impact factor: 4.432

10.  The relationship between nerve terminal adenosine triphosphatases and neurotransmitter release: as determined by the use of antidepressant and other CNS-active drugs.

Authors:  J C Gilbert; M G Wyllie
Journal:  Br J Pharmacol       Date:  1980-06       Impact factor: 8.739

View more
  6 in total

1.  Chronic treatment with reboxetine by osmotic pumps facilitates its effect on extracellular noradrenaline and may desensitize alpha(2)-adrenoceptors in the prefrontal cortex.

Authors:  R W Invernizzi; S Parini; G Sacchetti; C Fracasso; S Caccia; K Annoni; R Samanin
Journal:  Br J Pharmacol       Date:  2001-01       Impact factor: 8.739

2.  Acute or chronic changes of noradrenergic transmission do not affect the alpha-adrenoceptor-mediated inhibition of 3H-serotonin release in the cerebral cortex.

Authors:  E Schlicker; M Göthert; R Clausing
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1982-07       Impact factor: 3.000

3.  6-Hydroxydopamine pretreatment effects on alpha- and beta-adrenergic receptor adaptation to clorgyline.

Authors:  R M Cohen; C Aulakh; C McLellan; D L Murphy
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1985-04       Impact factor: 3.000

4.  Selective alteration of neurotransmitter release by low oxygen in vitro.

Authors:  J A Hirsch; G E Gibson
Journal:  Neurochem Res       Date:  1984-08       Impact factor: 3.996

5.  Presynaptic serotonin receptors regulate the release of 3H-serotonin in hypothalamic slices of the rabbit.

Authors:  T J Verbeuren; E P Coen; A Schoups; R Van de Velde; R Baeyens; W P De Potter
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1984-09       Impact factor: 3.000

6.  Glial alpha 2-receptors probably inhibit the high-affinity uptake of noradrenaline into astrocytes in the rat brain in vivo.

Authors:  G Köster
Journal:  Neurochem Res       Date:  1995-03       Impact factor: 3.996

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.